These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6262364)

  • 1. Development and evaluation of a method for the partial purification of immunoglobulins specific for Graves' disease.
    Endo K; Amir SM; Ingbar SH
    J Clin Endocrinol Metab; 1981 Jun; 52(6):1113-23. PubMed ID: 6262364
    [No Abstract]   [Full Text] [Related]  

  • 2. Isoelectric focusing of thyroid-stimulating antibody of Graves' disease.
    Zakarija M; McKenzie JM
    Endocrinology; 1978 Oct; 103(4):1469-75. PubMed ID: 33803
    [No Abstract]   [Full Text] [Related]  

  • 3. Preparation of 125I-labeled receptor-purified Graves' immunoglobulins: properties of their binding to human thyroid membranes.
    Endo K; Borges M; Amir S; Ingbar SH
    J Clin Endocrinol Metab; 1982 Sep; 55(3):566-76. PubMed ID: 6284786
    [No Abstract]   [Full Text] [Related]  

  • 4. Thyroid-stimulating immunoglobulins in Graves' disease.
    Smith BR; Hall R
    Lancet; 1974 Aug; 2(7878):427-31. PubMed ID: 4137321
    [No Abstract]   [Full Text] [Related]  

  • 5. Interaction between thyroid-stimulating immunoglobulins and thyrotropin receptors in fat cell membranes.
    Kishihara M; Nakao Y; Baba Y; Matsukura S; Kuma K; Fujita T
    J Clin Endocrinol Metab; 1979 Nov; 49(5):706-11. PubMed ID: 226558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial characterization and clinical correlation of circulating human immunoglobulins directed against thyrotrophin binding sites in guinea pig fat cell membranes. Development of a direct enzyme immunoassay.
    Baker JR; Lukes YG; Smallridge RC; Berger M; Burman KD
    J Clin Invest; 1983 Oct; 72(4):1487-97. PubMed ID: 6138364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and measurement of fat cell-binding immunoglobulins: a new method applicable to the diagnosis and study of Graves' disease.
    Shinozawa T; Villadolid MC; Ingbar SH
    J Clin Endocrinol Metab; 1986 Jan; 62(1):1-9. PubMed ID: 2999173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrepancy between thyroid-stimulating and thyrotropin-binding inhibitory activities of Graves' immunoglobulin Gs assessed in the mouse.
    Shishiba Y; Ozawa Y; Ohtsuki N; Shimizu T
    J Clin Endocrinol Metab; 1982 Apr; 54(4):858-62. PubMed ID: 6277983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological aspects of Graves' disease and importance of thyroid stimulating immunoglobulins.
    Bech K
    Acta Endocrinol Suppl (Copenh); 1983; 254():3-38. PubMed ID: 6191508
    [No Abstract]   [Full Text] [Related]  

  • 10. Interaction between thyrotropin (TSH) binding inhibitor immunoglobulins (TBII) and soluble TSH receptors in fat cells.
    Kishihara M; Nakao Y; Baba Y; Kobayashi N; Matsukura S; Kuma K; Fujita T
    J Clin Endocrinol Metab; 1981 Apr; 52(4):665-70. PubMed ID: 6110672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in thyroid-stimulating immunoglobulins during antithyroid therapy.
    Fenzi G; Hashizume K; Roudebush CP; DeGroot LJ
    J Clin Endocrinol Metab; 1979 Apr; 48(4):572-6. PubMed ID: 581875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins.
    Heyma P; Harrison LC
    J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyrotropin displacement activity of serum immunoglobulins from patients with Graves' disease.
    O'Donnell J; Trokoudes K; Silverberg J; Row V; Volpé R
    J Clin Endocrinol Metab; 1978 May; 46(5):770-7. PubMed ID: 233633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new serum-based assay for fat cell-binding immunoglobulins: application to the detection of the thyrotropin receptor antibodies of Graves' disease.
    Shinozawa T; Villadolid MC; Ingbar SH
    J Clin Endocrinol Metab; 1986 Jan; 62(1):10-5. PubMed ID: 2999174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assays of thyroid-stimulating antibody.
    McKenzie JM; Zakarija M
    Methods Enzymol; 1985; 109():677-91. PubMed ID: 2859517
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of monoclonal antibodies raised against solubilized thyrotropin receptors in a cytochemical bioassay for thyroid stimulators.
    Ealey PA; Valente WA; Ekins RP; Kohn LD; Marshall NJ
    Endocrinology; 1985 Jan; 116(1):124-31. PubMed ID: 2856871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid stimulating immunoglobulins: measurement and clinical use.
    Ollis CA; Tomlinson S; Munro DS
    Clin Sci (Lond); 1985 Aug; 69(2):113-21. PubMed ID: 2866060
    [No Abstract]   [Full Text] [Related]  

  • 18. On the effect of thyrotropin and immunoglobulins related to Graves' disease on thyrotropin synthesis and secretion.
    Dandona P; El Kabir DJ
    Clin Endocrinol (Oxf); 1978 Oct; 9(4):321-7. PubMed ID: 581481
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationship between exophthalmogenic and thyroid-stimulating immunoglobulins in Graves' endocrine ophthalmopathy.
    Leövey A; Kálmán K; Szabó T; Lente K; Sándor P; Balázs C
    Acta Med Acad Sci Hung; 1980; 37(4):345-50. PubMed ID: 6263033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production, isolation, and characterization of rabbit anti-idiotypic antibodies directed against human antithyrotrophin receptor antibodies.
    Baker JR; Lukes YG; Burman KD
    J Clin Invest; 1984 Aug; 74(2):488-95. PubMed ID: 6086714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.